The Pneumonia Diagnostics & Technologies Market size is estimated to reach $3.8 billion by 2028, growing at a CAGR of 8.5% during the forecast period 2023-2028. By product type, Pneumonia Diagnostics & Technologies Market can be segmented into consumables and analyzers. Immunodiagnostics utilizes the capability of antibodies to particularly bind to an antigen of interest. Molecular diagnostics has been the single principal development in pneumonia diagnostics over recent years.